Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Transnational Cannabis's Revenue for the
three
months ended in Nov. 2019 was $0.00 Mil. Transnational Cannabis's Total Assets for the quarter that ended in Nov. 2019 was $96.62 Mil. Therefore, Transnational Cannabis's Asset Turnover for the quarter that ended in Nov. 2019 was 0.00.
Asset Turnover is linked to ROE % through Du Pont Formula. Transnational Cannabis's annualizedROE % for the quarter that ended in Nov. 2019 was -110.04%. It is also linked to ROA % through Du Pont Formula. Transnational Cannabis's annualizedROA % for the quarter that ended in Nov. 2019 was -81.41%.
Note:
The Net Income data used here is four times the quarterly (Nov. 2019) net income data. The Revenue data used here is four times the quarterly (Nov. 2019) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.
It is also linked to ROA % through Du Pont Formula:
Transnational Cannabis's annulizedROA % for the quarter that ended in Nov. 2019 is
Note:
The Net Income data used here is four times the quarterly (Nov. 2019) net income data. The Revenue data used here is four times the quarterly (Nov. 2019) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.
Transnational Cannabis Asset Turnover Related Terms
Transnational Cannabis Asset Turnover Historical Data
* Premium members only.
The historical data trend for Transnational Cannabis's Asset Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TRCNF vs CLSH, KAYS, ACUR: Asset Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Transnational Cannabis's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transnational Cannabis Asset Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Transnational Cannabis's Asset Turnover distribution charts can be found below:
* The bar in red indicates where Transnational Cannabis's Asset Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.
Transnational Cannabis (TRCNF) has a Asset Turnover of 0.00 as of Nov. 2019. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Transnational Cannabis and its competitors.
Is Transnational Cannabis' Asset Turnover too high?
Transnational Cannabis' current Asset Turnover is 0.00.
How does Transnational Cannabis' Asset Turnover compare to CLSH and KAYS?
Transnational Cannabis' Asset Turnover of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Transnational Cannabis and its competitors. Transnational Cannabis's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transnational Cannabis stock overvalued right now?
Transnational Cannabis (TRCNF) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Transnational Cannabis (TRCNF), the current Asset Turnover is 0.00 as of Nov. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Transnational Cannabis Ltd, formerly ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa, and Denmark.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRCNF has been successfully added to your 
